Middle East & AfricaDrug Modelling Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type (Database, Software, and Others); and Application (Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, and Others) and Country

Publication Month: Oct 2020 | Report Code: TIPRE00015159 | No. of Pages: 109 | Category: Healthcare IT | Status: Published
Covid

The Middle East & Africadrug modelling softwaremarketis expected to reach US$ 297.94 million by 2027 from US$ 487.02 million in 2019; it is estimated to grow at a CAGR of 6.6% from 2020 to 2027.

Increasing adoption of in-silico modelling tools in drug discovery, and increasing economic burden of drug discoveryin the region are the key factors driving the growth of drug modelling software. However,less adoption in emerging countries is the major factor hindering the market growth in Middle East & Africa.

 

Drug modelling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key role in the development of novel drugs. Software based methods such as molecular modelling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. In addition, appropriate implementation of these techniques may help in reducing cost of drug designing and development.

 

The discovery and development of new drugs with potential therapeutic applications is a complex, expensive, and time-consuming venture. Considering this challenge, many novel technologies have been developed to increase the efficiency of the drug discovery process. Computational methodologies have become a crucial part of several drug discovery programs. From hit identification to lead optimization, techniques such as ligand or structure-based virtual screening are widely being used by many pharmaceutical companies. With the help of modelling, existing data can be leveraged to gain insights on product safety and effectiveness. Nowadays, In-Silico design (computer-aided) is being utilized to expedite and facilitate hit identification, optimize the absorption, distribution, metabolism, and toxicity profile to avoid safety issues. Commonly used in-silico approaches include ligand-based drug design, structure-based drug design, and quantitative structure-activity.

 

Moreover, various pharmaceutical companies have started adopting these techniques for better outcomes. Large Indian pharmaceutical firms have taken different routes toward “innovative drug discovery”. The mode is to set up in-house “NCE discovery units”, which serve as the innovation engine. A variation of this theme is to establish biotech-like drug discovery units outside the country and drive discovery and development through this collaborative medium. These approaches have seen steady increase in the number of compounds in clinical development.  Moreover, many research organizations have also started adopting drug modelling technologies for expediting the research process. For instance, NYU Abu Dhabi researchers design new technology for targeted cancer drug delivery. A team of researchers at NYU Abu Dhabi has developed a biocompatible, biodegradable, and economical nanocarrier for safer and more effective delivery of anticancer drugs. Researchers demonstrate that the novel pH-responsive hybrid (i.e. multi-component) nanoparticles can be loaded with a wide range of chemotherapeutics to effectively and specifically target cancer cells, as reported in their paper published on March 3, 2020, in the journal Communications Biology. Thus, above mentioned factors are expected to drive the growth of the drug modelling software market during the forecast period.

 

The countries in this region are sequencing complete COVID-19 genome. For instance, a new initiative to study and identify genetic factors that cause symptoms of the coronavirus disease (COVID-19) among Saudis has been launched in Riyadh, as part of the Kingdom’s efforts to tackle the pandemic. The initiative will help in developing national genetic databases in cooperation with the health sector and developing solutions and strategic plans to protect the population of the Kingdom and those most at risk of contracting the disease, in addition to increasing the efficiency of current treatment methods and the development of new drugs. Thus, continuous research on COVID-19 using drug discovery platforms is expected to fuel the growth of the market.

 

Rest of Middle East & AfricaDrug Modelling Software Market,Revenue and Forecast to 2027 (US$ Mn)

Rest of Middle East & AfricaDrug Modelling Software Market,Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :


 

MIDDLE EAST & AFRICADRUG MODELLING SOFTWARE MARKET SEGMENTATION

 

By Product Type

  • Database
  • Software
  • Others

 

By Application

  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modeling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
  • Simulation Software
  • Cellular Simulation
  • Others

 

By Country

  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa

 

Company Profiles

  • Crown Bioscience Inc (JSR life science)
  • Compugen Ltd.
  • Biognos AB
  • Dassault Systèmes
  • Acellera

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Drug Modelling Software Market – By Product Type

1.3.2        Middle East & Africa Drug Modelling Software Market – By Application

1.3.3        Middle East & Africa Drug Modelling Software Market – By Country

2.           Middle East & Africa Drug Modelling Software Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Drug Modelling Software Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Drug Modelling Software Market - Middle East & Africa PEST Analysis

4.3         Expert Opinion

5.           Middle East & Africa Drug Modelling Software Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Adoption of Modelling Tools in Drug Discovery

5.1.2        Increasing Economic Burden of Drug Discovery

5.2         Key Market Restraints

5.2.1        Less Adoption in Emerging Countries

5.3         Key Market Opportunities

5.3.1        Strategic Activities by Market Players

5.4         Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5         Impact analysis

6.           Drug Modelling Software Market – Middle East & Africa Analysis

6.1         Middle East & Africa Drug Modelling Software Market Revenue Forecasts and Analysis

7.           Middle East & Africa Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type

7.1         Overview

7.2         Middle East & Africa Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

7.2.1        Middle East & Africa Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.3         Database

7.3.1        Overview

7.3.2        Middle East & Africa Database Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Software

7.4.1        Overview

7.4.1.1          Middle East & Africa Software Revenue and Forecasts to 2027 (US$ Mn)

7.5         Other Product Types

7.5.1        Overview

7.5.2        Middle East & Africa Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)

8.           Middle East & Africa Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application

8.1         Overview

8.2         Middle East & Africa Drug Modelling Software Market, By Application 2019 & 2027 (%)

8.2.1        Middle East & Africa Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Middle East & Africa Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)

8.4         Computational Physiological Medicine

8.4.1        Overview

8.4.2        Middle East & Africa Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Disease Modelling

8.5.1        Overview

8.5.2        Middle East & Africa Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Medical Imaging

8.6.1        Overview

8.6.2        Middle East & Africa Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Predictive Analysis of Drug Targets

8.7.1        Overview

8.7.2        Middle East & Africa Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Simulation Software

8.8.1        Overview

8.8.2        Middle East & Africa Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.9         Cellular Simulation

8.9.1        Overview

8.9.2        Middle East & Africa Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

8.10      Others

8.10.1     Overview

8.10.2     Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         Middle East & Africa Drug modelling software Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        Middle East & Africa: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)

9.1.3        Middle East & Africa Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

9.1.4        Middle East & Africa Drug Modelling Software Market, by Application– Revenue and Forecast to 2027  (USD Million)

9.1.5        Middle East & Africa: Drug Modelling Software Market, by Country, 2018 & 2027 (%)

9.1.6        Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          Saudi Arabia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.7        UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

9.1.7.3          UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

9.1.8        South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Middle East & Africa Drug Modelling Software Market

10.1      Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Compugen Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Biognos AB

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Dassault Systèmes

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Acellera

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.5      Crown Bioscience Inc (JSR life science)

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East & Africa Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             Middle East & Africa Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.             Middle East & Africa Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

Table 4.             Middle East & Africa Drug Modelling Software Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 5.             Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

Table 8.             UAE Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Glossary of Terms, Drug Modelling Software Market

LIST OF FIGURES

Figure 1.           Drug Modelling Software Market Segmentation

Figure 2.           Middle East & Africa Drug Modelling Software Market Overview

Figure 3.           Software Segment Held Largest Share of Drug Modelling Software Market

Figure 4.           Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Middle East & Africa Drug Modelling Software Market - Leading Country Markets (US$ Mn)

Figure 6.           Drug Modelling Software Market - Middle East & Africa PEST Analysis

Figure 7.           Drug Modelling Software Market Impact Analysis of Driver and Restraints

Figure 8.           Middle East & Africa Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Middle East & Africa Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

Figure 10.        Middle East & Africa Database Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Middle East & Africa Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Middle East & Africa Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Middle East & Africa Drug Modelling Software Market, By Application 2019 & 2027 (%)

Figure 14.        Middle East & Africa Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Middle East & Africa Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Middle East & Africa Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Middle East & Africa Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Middle East & Africa Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Middle East & Africa Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Middle East & Africa Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Middle East & Africa: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        Middle East & Africa Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        Middle East & Africa: Drug Modelling Software Market, by Country, 2018 & 2027 (%)

Figure 25.        Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

  1. Crown Bioscience Inc (JSR life science)
  2. Compugen Ltd.
  3. Biognos AB
  4. Dassault Systèmes
  5. Acellera
  • It provides understanding of the Middle East & Africa, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East & Africadrug modelling software market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling softwaremarket by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis ofdrug modelling software market performance of various segments pertaining to the Middle East & Africadrug modelling software market.
  • It providesdrug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.
TIPRE00015159
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing